Position in EXEL
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$54,410
+$11,520 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#171
of 240 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MB, LEVIS & ASSOCIATES, LLC holds $106,347 across 4 Biotechnology names. EXEL ranks #1 (51.2% of the industry book) .
All Filings in EXEL
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,410 | 1,000 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $42,890 | 1,000 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $43,830 | 1,000 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $41,300 | 1,000 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $44,080 | 1,000 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $36,920 | 1,000 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $33,300 | 1,000 | Shares | Sole | 2025-05-07 | |
| 2024-09-30 | $25,950 | 1,000 | Shares | Sole | 2025-05-07 | |
| 2024-06-30 | $22,470 | 1,000 | Shares | Sole | 2025-05-07 | |
| 2024-03-31 | $23,730 | 1,000 | Shares | Sole | 2025-05-07 | |
| 2023-12-31 | $59,975 | 2,500 | Shares | Sole | 2025-05-07 | |
| 2023-09-30 | $65,550 | 3,000 | Shares | Sole | 2025-05-07 | |
| 2023-06-30 | $57,330 | 3,000 | Shares | Sole | 2025-05-07 | |
| 2023-03-31 | $58,230 | 3,000 | Shares | Sole | 2025-05-07 | |
| 2022-12-31 | $48,120 | 3,000 | Shares | Sole | 2025-05-07 | |
| No filing history on record for this holder in this stock. | ||||||